5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.88▼ | 4.88▼ | 4.87▼ | 4.92▼ | 4.85▲ |
MA10 | 4.87▲ | 4.88▼ | 4.88▼ | 4.82▲ | 6.42▼ |
MA20 | 4.88▼ | 4.87▼ | 4.87▼ | 4.85▲ | 7.46▼ |
MA50 | 4.87▼ | 4.89▼ | 4.91▼ | 6.88▼ | 6.68▼ |
MA100 | 4.86▲ | 4.90▼ | 4.85▲ | 7.32▼ | 4.41▲ |
MA200 | 4.88▼ | 4.85▲ | 5.44▼ | 6.56▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.002▲ | 0.002▲ | 0.142▲ | -0.501▼ |
RSI | 48.191▼ | 49.331▼ | 48.866▼ | 39.517▼ | 42.006▼ |
STOCH | 66.204 | 56.124 | 67.057 | 59.645 | 5.953▼ |
WILL %R | -55.556 | -38.462 | -32.609 | -47.826 | -93.213▼ |
CCI | 40.613 | -6.364 | 32.612 | -11.801 | -86.752 |
Friday, April 25, 2025 11:51 AM
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological ...
|
Wednesday, April 23, 2025 01:15 PM
Candel Therapeutics announced an oral presentation of CAN-2409 data at the ASCO Annual Meeting, focusing on prostate cancer treatment. Candel Therapeutics, Inc. announced the acceptance of an ...
|
Tuesday, April 22, 2025 07:39 AM
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 4.91 | 4.945 | 4.70 | 4.89 | 876,961 |
30/04/25 | 4.74 | 4.935 | 4.70 | 4.91 | 666,095 |
29/04/25 | 4.835 | 4.94 | 4.83 | 4.83 | 390,061 |
28/04/25 | 5.04 | 5.1888 | 4.87 | 4.97 | 942,823 |
25/04/25 | 4.97 | 5.025 | 4.80 | 4.98 | 903,782 |
24/04/25 | 5.02 | 5.25 | 4.93 | 5.00 | 2,134,796 |
23/04/25 | 5.00 | 5.1391 | 4.75 | 4.76 | 2,096,480 |
22/04/25 | 4.60 | 4.85 | 4.60 | 4.735 | 527,819 |
21/04/25 | 4.48 | 4.81 | 4.41 | 4.51 | 385,546 |
17/04/25 | 4.61 | 4.78 | 4.50 | 4.57 | 534,504 |
|
|
||||
|
|
||||
|
|